- Thursday, June 15, 2023
12:00 PM – 1:00 PM .
Welcome and Session I: 2023 Updates in IBD ManagementSpeaker: – University of North Carolina at Chapel Hill
Speaker: – Cleveland Clinic
12:00 PM – 1:00 PM .
Welcome and Session I: 2023 Updates in IBD ManagementSpeaker: – University of North Carolina at Chapel Hill
Speaker: – Cleveland Clinic
Millie D. Long, MD, MPH, FACG – University of North Carolina at Chapel Hill ### 728465###Speaker###Professor of Medicine###University of North Carolina at Chapel Hill###Speaker: – University of North Carolina at Chapel Hill
### @@@ Florian Rieder, MD – Cleveland Clinic ### 988230###Speaker###Vice Department Chair, Co-Section Head Inflammatory Bowel Disease and Director of IBD Research; 2019 Sherman Emerging Leader Prize Recipient###Cleveland Clinic###Speaker: – Cleveland Clinic
### 12:00 PM – 12:15 PM .
WelcomeSpeaker: – Northwestern University Feinberg School of Medicine
Stephen B. Hanauer, MD, MACG – Northwestern University Feinberg School of Medicine ### 594414###Speaker###Medical Director of Digestive Health Center###Northwestern University Feinberg School of Medicine###Speaker: – Northwestern University Feinberg School of Medicine
### 12:15 PM – 12:35 PM .
Update on the Management of UCSpeaker: – University of North Carolina at Chapel Hill
Millie D. Long, MD, MPH, FACG – University of North Carolina at Chapel Hill ### 728465###Speaker###Professor of Medicine###University of North Carolina at Chapel Hill###Speaker: – University of North Carolina at Chapel Hill
### 12:35 PM – 12:55 PM .
Stricturing Crohn's DiseaseSpeaker: – Cleveland Clinic
Florian Rieder, MD – Cleveland Clinic ### 988230###Speaker###Vice Department Chair, Co-Section Head Inflammatory Bowel Disease and Director of IBD Research; 2019 Sherman Emerging Leader Prize Recipient###Cleveland Clinic###Speaker: – Cleveland Clinic
### 12:55 PM – 1:00 PM .
Q&A Panel
1:15 PM – 2:15 PM .
Non-CME Innovation Theater: Case by Case: an expert-led patient case study that reviews a hypothetical patient treated with SKYRIZI for moderate to severe CD
1:15 PM – 2:15 PM .
Non-CME Innovation Theater: Case by Case: an expert-led patient case study that reviews a hypothetical patient treated with SKYRIZI for moderate to severe CD
2:30 PM – 3:15 PM .
Session II: Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management StrategiesSpeaker: – Cleveland Clinic
2:30 PM – 3:15 PM .
Session II: Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management StrategiesSpeaker: – Cleveland Clinic
Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his) – Cleveland Clinic ### 742752###Speaker###IBD Surgery Section Chief; Director of Research; Department of Colon & Rectal Surgery###Cleveland Clinic###Speaker: – Cleveland Clinic
### he/him/his2:30 PM – 3:00 PM .
Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management StrategiesSpeaker: – Cleveland Clinic
Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his) – Cleveland Clinic ### 742752###Speaker###IBD Surgery Section Chief; Director of Research; Department of Colon & Rectal Surgery###Cleveland Clinic###Speaker: – Cleveland Clinic
### he/him/his3:00 PM – 3:15 PM .
Q&A Panel
3:30 PM – 4:30 PM .
Non-CME Innovation Theater: Exploring a Prescription Treatment for Patients With Moderately to Severely Active Ulcerative Colitis, Including Long-Term Data
3:30 PM – 4:30 PM .
Non-CME Innovation Theater: Exploring a Prescription Treatment for Patients With Moderately to Severely Active Ulcerative Colitis, Including Long-Term Data
4:45 PM – 5:30 PM .
Session III: Strategies to Address Barriers and Optimize Outcomes in Luminal Crohn’s DiseaseSpeaker: – Cleveland Clinic
4:45 PM – 5:30 PM .
Session III: Strategies to Address Barriers and Optimize Outcomes in Luminal Crohn’s DiseaseSpeaker: – Cleveland Clinic
Florian Rieder, MD – Cleveland Clinic ### 988230###Speaker###Vice Department Chair, Co-Section Head Inflammatory Bowel Disease and Director of IBD Research; 2019 Sherman Emerging Leader Prize Recipient###Cleveland Clinic###Speaker: – Cleveland Clinic
### 4:45 PM – 5:15 PM .
Strategies to Address Barriers and Optimize Outcomes in Luminal Crohn’s DiseaseSpeaker: – Cleveland Clinic
Florian Rieder, MD – Cleveland Clinic ### 988230###Speaker###Vice Department Chair, Co-Section Head Inflammatory Bowel Disease and Director of IBD Research; 2019 Sherman Emerging Leader Prize Recipient###Cleveland Clinic###Speaker: – Cleveland Clinic
### 5:15 PM – 5:30 PM .
Q&A Panel
- Friday, June 16, 2023
8:00 AM – 8:45 AM .
Session VI: Special Situations in UCSpeaker: – University of Maryland School of Medicine
Speaker: – University of Chicago Medicine
8:00 AM – 8:45 AM .
Session VI: Special Situations in UCSpeaker: – University of Maryland School of Medicine
Speaker: – University of Chicago Medicine
Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his) – University of Maryland School of Medicine ### 728455###Speaker###Professor of Medicine, Director of the IBD Program###University of Maryland School of Medicine###Speaker: – University of Maryland School of Medicine
### he/him/his @@@ David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine ### 706904###Speaker###Professor of Medicine; Professor of Pathology###University of Chicago Medicine###Speaker: – University of Chicago Medicine
### he/him/his8:00 AM – 8:15 AM .
Management of the Hospitalized UC PatientSpeaker: – University of Maryland School of Medicine
Raymond K. Cross, Jr., MD, MS, AGAF, FACG – University of Maryland School of Medicine ### 728455###Speaker###Professor of Medicine, Director of the IBD Program###University of Maryland School of Medicine###Speaker: – University of Maryland School of Medicine
### 8:15 AM – 8:30 AM .
Dysplasia in IBD: Best PracticesSpeaker: – University of Chicago Medicine
David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine ### 706904###Speaker###Professor of Medicine; 2020 Sherman Prize Recipient###University of Chicago Medicine###Speaker: – University of Chicago Medicine
### he/him/his8:30 AM – 8:45 AM .
Q&A Panel
9:00 AM – 10:00 AM .
Session V: Utilizing our Therapeutic Armamentarium: Right Patient/Right DrugSpeaker: – University of Chicago Medicine
Speaker: – Cleveland Clinic
Speaker: – Cedars-Sinai Medical Center
9:00 AM – 10:00 AM .
Session V: Utilizing our Therapeutic Armamentarium: Right Patient/Right DrugSpeaker: – University of Chicago Medicine
Speaker: – Cleveland Clinic
Speaker: – Cedars-Sinai Medical Center
David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine ### 706904###Speaker###Professor of Medicine; Professor of Pathology###University of Chicago Medicine###Speaker: – University of Chicago Medicine
### he/him/his @@@ Florian Rieder, MD – Cleveland Clinic ### 988230###Speaker###Vice Department Chair, Co-Section Head Inflammatory Bowel Disease and Director of IBD Research; 2019 Sherman Emerging Leader Prize Recipient###Cleveland Clinic###Speaker: – Cleveland Clinic
### @@@ Gil Y. Melmed, MD, MS, FACG, AGAF – Cedars-Sinai Medical Center ### 697857###Speaker###Director, IBD Clinical Research, F. Widjadja IBD Institute###Cedars-Sinai Medical Center###Speaker: – Cedars-Sinai Medical Center
### 9:00 AM – 9:15 AM .
Small But Mighty: JAK InhibitorsSpeaker: – University of Chicago Medicine
David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine ### 706904###Speaker###Professor of Medicine; 2020 Sherman Prize Recipient###University of Chicago Medicine###Speaker: – University of Chicago Medicine
### he/him/his9:15 AM – 9:30 AM .
'Old' But True: Anti-TNF and Anti-IntegrinsSpeaker: – Cleveland Clinic
Florian Rieder, MD – Cleveland Clinic ### 988230###Speaker###Vice Department Chair, Co-Section Head Inflammatory Bowel Disease and Director of IBD Research; 2019 Sherman Emerging Leader Prize Recipient###Cleveland Clinic###Speaker: – Cleveland Clinic
### 9:30 AM – 9:45 AM .
The 'New' Wave: Anti-Interleukins Are HereSpeaker: – Cedars-Sinai Medical Center
Gil Y. Melmed, MD, MS, FACG, AGAF – Cedars-Sinai Medical Center ### 697857###Speaker###Director, IBD Clinical Research, F. Widjadja IBD Institute###Cedars-Sinai Medical Center###Speaker: – Cedars-Sinai Medical Center
### 9:45 AM – 10:00 AM .
Q&A Panel
10:15 AM – 11:15 AM .
Non-CME Innovation Theater: A Treatment Option That Can Be Used Before Biologics For Your Moderate UC Patients
10:15 AM – 11:15 AM .
Non-CME Innovation Theater: A Treatment Option That Can Be Used Before Biologics For Your Moderate UC Patients
11:30 AM – 12:15 PM .
Session VI: Optimizing Existing Therapies in the Management of IBDSpeaker: – Brigham and Women's Hospital, Harvard Medical School
11:30 AM – 12:15 PM .
Session VI: Optimizing Existing Therapies in the Management of IBDSpeaker: – Brigham and Women's Hospital, Harvard Medical School
Jessica R. Allegretti, MD,MPH, FACG, AGAF – Brigham and Women's Hospital, Harvard Medical School ### 742672###Speaker###Director, Crohn's and Colitis Center; Associate Professor of Medicine, 2020 Sherman Prize Emerging Leader Recipient###Brigham and Women's Hospital, Harvard Medical School###Speaker: – Brigham and Women's Hospital, Harvard Medical School
### 11:30 AM – 12:00 PM .
Optimizing Existing Therapies in the Management of IBDSpeaker: – Brigham and Women's Hospital, Harvard Medical School
Jessica R. Allegretti, MD,MPH, FACG, AGAF – Brigham and Women's Hospital, Harvard Medical School ### 742672###Speaker###Director, Crohn's and Colitis Center; Associate Professor of Medicine, 2020 Sherman Prize Emerging Leader Recipient###Brigham and Women's Hospital, Harvard Medical School###Speaker: – Brigham and Women's Hospital, Harvard Medical School
### 12:00 PM – 12:15 PM .
Q&A Panel
12:30 PM – 1:15 PM .
Session VII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBDSpeaker: – University of Maryland School of Medicine
12:30 PM – 1:15 PM .
Session VII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD Speaker: – University of Maryland School of Medicine
Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his) – University of Maryland School of Medicine ### 728455###Speaker###Professor of Medicine, Director of the IBD Program###University of Maryland School of Medicine###Speaker: – University of Maryland School of Medicine
### he/him/his12:30 PM – 1:00 PM .
Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD Speaker: – University of Maryland School of Medicine
Raymond K. Cross, Jr., MD, MS, AGAF, FACG – University of Maryland School of Medicine ### 728455###Speaker###Professor of Medicine, Director of the IBD Program###University of Maryland School of Medicine###Speaker: – University of Maryland School of Medicine
### 1:00 PM – 1:15 PM .
Q&A Panel
1:30 PM – 2:30 PM .
Non-CME Innovation Theater: UC Results: a peer-to-peer review of clinical outcomes and long-term safety of a JAK inhibitor for patients with UC
1:30 PM – 2:30 PM .
Non-CME Innovation Theater: UC Results: a peer-to-peer review of clinical outcomes and long-term safety of a JAK inhibitor for patients with UC
2:45 PM – 3:30 PM .
Session VIII: Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel DiseaseSpeaker: – Mayo Clinic Scottsdale
2:45 PM – 3:30 PM .
Session VIII: Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel DiseaseSpeaker: – Mayo Clinic Scottsdale
Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale ### 697861###Speaker###Associate Professor of Medicine###Mayo Clinic Scottsdale###Speaker: – Mayo Clinic Scottsdale
### 2:45 PM – 3:15 PM .
Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel DiseaseSpeaker: – Mayo Clinic Scottsdale
Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale ### 697861###Speaker###Associate Professor of Medicine###Mayo Clinic Scottsdale###Speaker: – Mayo Clinic Scottsdale
### 3:15 PM – 3:30 PM .
Q&A Panel
3:45 PM – 4:30 PM .
Session IX: Putting your knowledge to the test: Challenging IBD cases
3:45 PM – 4:30 PM .
Session IX: Putting your knowledge to the test: Challenging IBD cases
3:45 PM – 4:30 PM .
Putting your knowledge to the test: Challenging IBD cases
- Friday, July 21, 2023
12:00 PM – 12:15 PM .
Session I
12:00 PM – 12:15 PM .
Welcome
12:15 PM – 1:00 PM .
Session I - 2023 Updates in IBD ManagementSpeaker: – University of North Carolina at Chapel Hill
Speaker: – Cleveland Clinic
12:15 PM – 1:00 PM .
Session I - 2023 Updates in IBD ManagementSpeaker: – University of North Carolina at Chapel Hill
Speaker: – Cleveland Clinic
Millie D. Long, MD, MPH, FACG – University of North Carolina at Chapel Hill ### 728465###Speaker###Professor of Medicine###University of North Carolina at Chapel Hill###Speaker: – University of North Carolina at Chapel Hill
### @@@ Florian Rieder, MD – Cleveland Clinic ### 988230###Speaker###Vice Department Chair, Co-Section Head Inflammatory Bowel Disease and Director of IBD Research; 2019 Sherman Emerging Leader Prize Recipient###Cleveland Clinic###Speaker: – Cleveland Clinic
### 12:15 PM – 12:35 PM .
Update on the management of UCSpeaker: – University of North Carolina at Chapel Hill
Millie D. Long, MD, MPH, FACG – University of North Carolina at Chapel Hill ### 728465###Speaker###Professor of Medicine###University of North Carolina at Chapel Hill###Speaker: – University of North Carolina at Chapel Hill
### 12:35 PM – 12:55 PM .
Stricturing Crohn's DiseaseSpeaker: – Cleveland Clinic
Florian Rieder, MD – Cleveland Clinic ### 988230###Speaker###Vice Department Chair, Co-Section Head Inflammatory Bowel Disease and Director of IBD Research; 2019 Sherman Emerging Leader Prize Recipient###Cleveland Clinic###Speaker: – Cleveland Clinic
### 12:55 PM – 1:00 PM .
Q&A Panel
1:15 PM – 2:15 PM .
Non-CME Innovation Theater
1:15 PM – 2:15 PM .
Non-CME Innovation Theater
2:45 PM – 3:30 PM .
Session II - Optimizing Existing Therapies in the Management of IBDSpeaker: – Brigham and Women's Hospital, Harvard Medical School
2:45 PM – 3:30 PM .
Session II - Optimizing Existing Therapies in the Management of IBDSpeaker: – Brigham and Women's Hospital, Harvard Medical School
Jessica R. Allegretti, MD,MPH, FACG, AGAF – Brigham and Women's Hospital, Harvard Medical School ### 742672###Speaker###Director, Crohn's and Colitis Center; Associate Professor of Medicine, 2020 Sherman Prize Emerging Leader Recipient###Brigham and Women's Hospital, Harvard Medical School###Speaker: – Brigham and Women's Hospital, Harvard Medical School
### 2:45 PM – 3:15 PM .
Optimizing Existing Therapies in the Management of IBDSpeaker: – Brigham and Women's Hospital, Harvard Medical School
Jessica R. Allegretti, MD,MPH, FACG, AGAF – Brigham and Women's Hospital, Harvard Medical School ### 742672###Speaker###Director, Crohn's and Colitis Center; Associate Professor of Medicine, 2020 Sherman Prize Emerging Leader Recipient###Brigham and Women's Hospital, Harvard Medical School###Speaker: – Brigham and Women's Hospital, Harvard Medical School
### 3:15 PM – 3:30 PM .
Q&A Panel
3:45 PM – 4:45 PM .
Non-CME Innovation Theater
3:45 PM – 4:45 PM .
Non-CME Innovation Theater
5:00 PM – 5:45 PM .
Session III - Strategies to Address Barriers and Optimize Outcomes in Luminal Crohn’s DiseaseSpeaker: – Cleveland Clinic
5:00 PM – 5:45 PM .
Session III - Strategies to Address Barriers and Optimize Outcomes in Luminal Crohn’s DiseaseSpeaker: – Cleveland Clinic
Florian Rieder, MD – Cleveland Clinic ### 988230###Speaker###Vice Department Chair, Co-Section Head Inflammatory Bowel Disease and Director of IBD Research; 2019 Sherman Emerging Leader Prize Recipient###Cleveland Clinic###Speaker: – Cleveland Clinic
### 5:00 PM – 5:30 PM .
Strategies to Address Barriers and Optimize Outcomes in Luminal Crohn’s DiseaseSpeaker: – Cleveland Clinic
Florian Rieder, MD – Cleveland Clinic ### 988230###Speaker###Vice Department Chair, Co-Section Head Inflammatory Bowel Disease and Director of IBD Research; 2019 Sherman Emerging Leader Prize Recipient###Cleveland Clinic###Speaker: – Cleveland Clinic
### 5:30 PM – 5:45 PM .
Q&A Panel
- Saturday, July 22, 2023
8:00 AM – 8:15 AM .
Session IV
8:00 AM – 8:15 AM .
Welcome
8:15 AM – 9:00 AM .
Session IV - Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management StrategiesSpeaker: – Cleveland Clinic
8:15 AM – 9:00 AM .
Session IV - Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management StrategiesSpeaker: – Cleveland Clinic
Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his) – Cleveland Clinic ### 742752###Speaker###IBD Surgery Section Chief; Director of Research; Department of Colon & Rectal Surgery###Cleveland Clinic###Speaker: – Cleveland Clinic
### he/him/his8:15 AM – 8:45 AM .
Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management StrategiesSpeaker: – Cleveland Clinic
Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his) – Cleveland Clinic ### 742752###Speaker###IBD Surgery Section Chief; Director of Research; Department of Colon & Rectal Surgery###Cleveland Clinic###Speaker: – Cleveland Clinic
### he/him/his8:45 AM – 9:00 AM .
Q&A Panel
9:15 AM – 10:30 AM .
Session V - Utilizing our Therapeutic Armamentarium: Right Patient/Right DrugSpeaker: – University of Chicago Medicine
Speaker: – Cleveland Clinic
Speaker: – Cedars-Sinai Medical Center
9:15 AM – 10:30 AM .
Session V - Utilizing our Therapeutic Armamentarium: Right Patient/Right DrugSpeaker: – University of Chicago Medicine
Speaker: – Cleveland Clinic
Speaker: – Cedars-Sinai Medical Center
David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine ### 706904###Speaker###Professor of Medicine; 2020 Sherman Prize Recipient###University of Chicago Medicine###Speaker: – University of Chicago Medicine
### he/him/his @@@ Florian Rieder, MD – Cleveland Clinic ### 988230###Speaker###Vice Department Chair, Co-Section Head Inflammatory Bowel Disease and Director of IBD Research; 2019 Sherman Emerging Leader Prize Recipient###Cleveland Clinic###Speaker: – Cleveland Clinic
### @@@ Gil Y. Melmed, MD, MS, FACG, AGAF – Cedars-Sinai Medical Center ### 697857###Speaker###Director, IBD Clinical Research, F. Widjadja IBD Institute###Cedars-Sinai Medical Center###Speaker: – Cedars-Sinai Medical Center
### 9:15 AM – 9:35 AM .
Small But Mighty: JAK InhibitorsSpeaker: – University of Chicago Medicine
David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine ### 706904###Speaker###Professor of Medicine; 2020 Sherman Prize Recipient###University of Chicago Medicine###Speaker: – University of Chicago Medicine
### he/him/his9:35 AM – 9:55 AM .
'Old' But True: Anti-TNF and Anti-IntegrinsSpeaker: – Cleveland Clinic
Florian Rieder, MD – Cleveland Clinic ### 988230###Speaker###Vice Department Chair, Co-Section Head Inflammatory Bowel Disease and Director of IBD Research; 2019 Sherman Emerging Leader Prize Recipient###Cleveland Clinic###Speaker: – Cleveland Clinic
### 9:55 AM – 10:15 AM .
The 'New' Wave: Anti-Interleukins Are HereSpeaker: – Cedars-Sinai Medical Center
Gil Y. Melmed, MD, MS, FACG, AGAF – Cedars-Sinai Medical Center ### 697857###Speaker###Director, IBD Clinical Research, F. Widjadja IBD Institute###Cedars-Sinai Medical Center###Speaker: – Cedars-Sinai Medical Center
### 10:15 AM – 10:30 AM .
Q&A Panel
10:30 AM – 11:00 AM .
Exhibit Hall Break
10:30 AM – 11:00 AM .
Exhibit Hall Break
11:00 AM – 12:00 PM .
Non-CME Innovation Theater
11:00 AM – 12:00 PM .
Non-CME Innovation Theater
12:15 PM – 1:00 PM .
Session VI - Special Situations in IBDSpeaker: – Mayo Clinic Scottsdale
Speaker: – Cleveland Clinic
12:15 PM – 1:00 PM .
Session VI - Special Situations in IBDSpeaker: – Mayo Clinic Scottsdale
Speaker: – Cleveland Clinic
Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale ### 697861###Speaker###Associate Professor of Medicine###Mayo Clinic Scottsdale###Speaker: – Mayo Clinic Scottsdale
### @@@ Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his) – Cleveland Clinic ### 742752###Speaker###IBD Surgery Section Chief; Director of Research; Department of Colon & Rectal Surgery###Cleveland Clinic###Speaker: – Cleveland Clinic
### he/him/his12:15 PM – 12:30 PM .
Pregnancy in IBDSpeaker: – Mayo Clinic Scottsdale
Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale ### 697861###Speaker###Associate Professor of Medicine###Mayo Clinic Scottsdale###Speaker: – Mayo Clinic Scottsdale
### 12:30 PM – 12:45 PM .
Perioperative Management of IBDSpeaker: – Cleveland Clinic
Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his) – Cleveland Clinic ### 742752###Speaker###IBD Surgery Section Chief; Director of Research; Department of Colon & Rectal Surgery###Cleveland Clinic###Speaker: – Cleveland Clinic
### he/him/his12:45 PM – 1:00 PM .
Q&A Panel
1:00 PM – 1:45 PM .
Session VII - Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD Speaker: – University of Maryland School of Medicine
1:00 PM – 1:45 PM .
Session VII - Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD Speaker: – University of Maryland School of Medicine
Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his) – University of Maryland School of Medicine ### 728455###Speaker###Professor of Medicine, Director of the IBD Program###University of Maryland School of Medicine###Speaker: – University of Maryland School of Medicine
### he/him/his1:00 PM – 1:30 PM .
Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD Speaker: – University of Maryland School of Medicine
Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his) – University of Maryland School of Medicine ### 728455###Speaker###Professor of Medicine, Director of the IBD Program###University of Maryland School of Medicine###Speaker: – University of Maryland School of Medicine
### he/him/his1:30 PM – 1:45 PM .
Q&A Panel
2:00 PM – 3:00 PM .
Non-CME Innovation Theater
2:00 PM – 3:00 PM .
Non-CME Innovation Theater
3:15 PM – 4:00 PM .
Session VIII - Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel DiseaseSpeaker: – Mayo Clinic Scottsdale
3:15 PM – 4:00 PM .
Session VIII - Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel DiseaseSpeaker: – Mayo Clinic Scottsdale
Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale ### 697861###Speaker###Associate Professor of Medicine###Mayo Clinic Scottsdale###Speaker: – Mayo Clinic Scottsdale
### 3:15 PM – 3:45 PM .
Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel DiseaseSpeaker: – Mayo Clinic Scottsdale
Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale ### 697861###Speaker###Associate Professor of Medicine###Mayo Clinic Scottsdale###Speaker: – Mayo Clinic Scottsdale
### 3:45 PM – 4:00 PM .
Q&A Panel
4:00 PM – 4:45 PM .
Session IX - Putting your knowledge to the test: Challenging IBD cases
4:00 PM – 4:45 PM .
Session IX - Putting your knowledge to the test: Challenging IBD cases
4:00 PM – 4:45 PM .
Case Panel
